At Amgen, we’re dedicated to fighting the misconception that osteoporosis is a normal part of aging. Osteoporosis affects more than 500 million people globally and causes more than 8.9 million fractures every year.1 One in three women over the age of 50 will experience an osteoporosis-related fracture in her lifetime,1 which can lead to pain, loss of mobility, and changes in lifestyle, including fear of falling and social isolation.2
But it doesn’t have to be that way. Amgen has developed innovative therapies to help patients improve their bone health and prevent fractures with medicines that work by both strengthening patients' existing bone, and simultaneously building new bone and slowing bone loss. We also work to increase the use of bone density testing (DXA scans) so people at risk for fractures can take preventative measures before fractures occur.
